Fluoxetine Signature on Hippocampal MAPK Signalling in Sex-Dependent Manner

详细信息    查看全文

• 作者：Milos Mitic (1)
  Iva Lukic (1)
  Natalija Bozovic (1)
  Jelena Djordjevic (1)
  Miroslav Adzic (1)
  
  1. Laboratory for Molecular Biology and Endocrinology ; Vinca Institute of Nuclear Sciences ; University of Belgrade ; P.O. Box 522 MBE090 ; 11001 ; Belgrade ; Serbia
  
• 关键词：Fluoxetine ; MAPK signalling ; Gender ; Chronic stress ; Hippocampus
• 刊名：Journal of Molecular Neuroscience
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：55
• 期：2
• 页码：335-346
• 全文大小：1,114 KB
• 参考文献：1. Adachi M, Fukuda M, Nishida E (1999) Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 18:5347鈥?358 CrossRef
  2. Adzic M, Djordjevic J, Djordjevic A, Niciforovic A, Demonacos C, Radojcic M, Krstic-Demonacos M (2009) Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol 202:87鈥?7 CrossRef
  3. Alonso J, Angermeyer MC, Bernert S et al (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 109:21鈥?7 CrossRef
  4. Andreetta F, Barnes NM, Wren PB, Carboni L (2013) p38 MAP kinase activation does not stimulate serotonin transport in rat brain: implications for sickness behaviour mechanisms. Life Sci 93:30鈥?7 CrossRef
  5. Bale TL (2006) Stress sensitivity and the development of affective disorders. Horm Behav 50:529鈥?33 CrossRef
  6. Battiwalla M, Hahn T, Radovic M et al (2006) Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence. Blood 107:1970鈥?973 CrossRef
  7. Bruchas MR, Schindler AG, Shankar H et al (2011) Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 71:498鈥?11 CrossRef
  8. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J (1999) Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664鈥?74 CrossRef
  9. Brust TB, Cayabyab FS, MacVicar BA (2007) C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus. Neuropharmacology 53:906鈥?17 CrossRef
  10. Budziszewska B, Szymanska M, Leskiewicz M et al (2010) The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J Physiol Pharmacol 61:207鈥?15
  11. Calabrese F, Molteni R, Racagni G, Riva MA (2009) Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34(Suppl 1):S208鈥揝216 CrossRef
  12. Djordjevic S, Kovacevic I, Miljkovic B, Vuksanovic J, Pokrajac M (2005) Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study. Farmaco 60:345鈥?49 CrossRef
  13. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116鈥?127 CrossRef
  14. Duman RS, Malberg J, Nakagawa S, D鈥橲a C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48:732鈥?39 CrossRef
  15. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS (2007) A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 61:661鈥?70 CrossRef
  16. Duric V, Banasr M, Licznerski P et al (2010) A negative regulator of MAP kinase causes depressive behavior. Nat Med 16:1328鈥?332 CrossRef
  17. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77:916鈥?28 CrossRef
  18. Dwivedi Y, Rizavi HS, Conley RR, Pandey GN (2006) ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 11:86鈥?8 CrossRef
  19. Feng P, Guan Z, Yang X, Fang J (2003) Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res 991:195鈥?05 CrossRef
  20. Flood DG, Finn JP, Walton KM et al (1998) Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J Comp Neurol 398:373鈥?92 CrossRef
  21. Fukuda M, Gotoh Y, Nishida E (1997) Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J 16:1901鈥?908 CrossRef
  22. Fumagalli F, Molteni R, Calabrese F, Frasca A, Racagni G, Riva MA (2005) Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 93:1551鈥?560 CrossRef
  23. Galeotti N, Ghelardini C (2012) Selective modulation of the PKCvarepsilon/p38MAP kinase signaling pathway for the antidepressant-like activity of amitriptyline. Neuropharmacology 62:289鈥?96 CrossRef
  24. Goel N, Bale TL (2009) Examining the intersection of sex and stress in modelling neuropsychiatric disorders. J Neuroendocrinol 21:415鈥?20 CrossRef
  25. Grewal SS, York RD, Stork PJ (1999) Extracellular-signal-regulated kinase signaling in neurons. Curr Opin Neurobiol 9:544鈥?53 CrossRef
  26. Hirsch DD, Stork PJ (1997) Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo. J Biol Chem 272:4568鈥?575 CrossRef
  27. Hisaoka K, Nishida A, Koda T et al (2001) Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 79:25鈥?4 CrossRef
  28. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477鈥?01 CrossRef
  29. Houslay MD, Kolch W (2000) Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 58:659鈥?68
  30. Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117:4619鈥?628 CrossRef
  31. Iio W, Matsukawa N, Tsukahara T, Kohari D, Toyoda A (2011) Effects of chronic social defeat stress on MAP kinase cascade. Neurosci Lett 504:281鈥?84 CrossRef
  32. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 109:649鈥?57 CrossRef
  33. Kessler RC (2003) Epidemiology of women and depression. J Affect Disord 74:5鈥?3 CrossRef
  34. Kondoh K, Torii S, Nishida E (2005) Control of MAP kinase signaling to the nucleus. Chromosoma 114:86鈥?1 CrossRef
  35. Kumar S, Boehm J, Lee JC (2003) p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717鈥?26 CrossRef
  36. Lenormand P, Brondello JM, Brunet A, Pouyssegur J (1998) Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J Cell Biol 142:625鈥?33 CrossRef
  37. Li H, Zhang L, Huang Q (2009) Differential expression of mitogen-activated protein kinase signaling pathway in the hippocampus of rats exposed to chronic unpredictable stress. Behav Brain Res 205:32鈥?7 CrossRef
  38. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265鈥?75
  39. Miller AL, Webb MS, Copik AJ et al (2005) p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:1569鈥?583 CrossRef
  40. Mitic M, Simic I, Djordjevic J, Radojcic MB, Adzic M (2013) Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats. Neuropharmacology 70:100鈥?11 CrossRef
  41. Moutsatsou P, Psarra AM, Tsiapara A, Paraskevakou H, Davaris P, Sekeris CE (2001) Localization of the glucocorticoid receptor in rat brain mitochondria. Arch Biochem Biophys 386:69鈥?8 CrossRef
  42. Muda M, Theodosiou A, Rodrigues N et al (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271:27205鈥?7208 CrossRef
  43. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER (2010) Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev 34:853鈥?66 CrossRef
  44. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, Nestler EJ (1995) Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15:1285鈥?297
  45. Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391鈥?04 CrossRef
  46. Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153鈥?83
  47. Pouyssegur J, Volmat V, Lenormand P (2002) Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem Pharmacol 64:755鈥?63 CrossRef
  48. Qi X, Lin W, Li J, Pan Y, Wang W (2006) The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res 175:233鈥?40 CrossRef
  49. Rogatsky I, Logan SK, Garabedian MJ (1998) Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci U S A 95:2050鈥?055 CrossRef
  50. Roskoski R Jr (2012) ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66:105鈥?43 CrossRef
  51. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320鈥?44 CrossRef
  52. Schaeffer HJ, Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435鈥?444
  53. Spencer RL, Kalman BA, Cotter CS, Deak T (2000) Discrimination between changes in glucocorticoid receptor expression and activation in rat brain using western blot analysis. Brain Res 868:275鈥?86 CrossRef
  54. Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76:1鈥?0 CrossRef
  55. Taler M, Bar M, Korob I et al (2008) Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. Int Immunopharmacol 8:526鈥?33 CrossRef
  56. Tiraboschi E, Tardito D, Kasahara J et al (2004) Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 29:1831鈥?840 CrossRef
  57. Todorovic C, Sherrin T, Pitts M, Hippel C, Rayner M, Spiess J (2009) Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology 34:1416鈥?426 CrossRef
  58. Torii S, Kusakabe M, Yamamoto T, Maekawa M, Nishida E (2004) Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell 7:33鈥?4 CrossRef
  59. Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK (2004) Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 25:1359鈥?370 CrossRef
  60. Tunquist BJ, Maller JL (2003) Under arrest: cytostatic factor (CSF)-mediated metaphase arrest in vertebrate eggs. Genes Dev 17:683鈥?10 CrossRef
  61. Wada T, Nakagawa K, Watanabe T et al (2001) Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4: different contribution of SEK2/MKK7 isoforms to the synergistic activation. J Biol Chem 276:30892鈥?0897 CrossRef
  62. Wang X, Wu H, Miller AH (2004) Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol Psychiatry 9:65鈥?5 CrossRef
  63. Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143鈥?80
  64. Willoughby EA, Collins MK (2005) Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J Biol Chem 280:25651鈥?5658 CrossRef
  65. Young EA, Korszun A (2002) The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin N Am 31:63鈥?8 CrossRef
  
• 刊物主题：Neurosciences; Neurochemistry; Cell Biology; Proteomics; Neurology;
• 出版者：Springer US
• ISSN：1559-1166

文摘

A growing body of evidence indicates that mitogen-activated protein kinase (MAPK) participates in various stress-induced responses and is considered to be one of the pathophysiological mechanisms in depression. Surprisingly, the effect of antidepressants on MAPKs is almost unexplored, particularly from the perspective of sexes. The present study investigates the cytoplasm-nuclear distribution of MAPK family, c-Jun N-terminal kinases (JNKs) 1, 2 and 3; extracellular signal-regulated kinases (ERKs) 1 and 2; and p38 kinases, as well as their phosphoisoforms in the hippocampus of chronically stressed female and male rats and upon chronic fluoxetine treatment. Additionally, we analysed crosstalk between MAPK signalling and depressive-like behaviour which correlated with brain-derived neurotrophic factor (BDNF) expression. Our results emphasize a gender-specific and compartment-dependent response of MAPKs to stress and fluoxetine. In females, stress decreased pp38 and pJNK and induced cytosolic retention of pERKs which reduced all nuclear pMAPKs. These changes correlated with altered BDNF expression and behaviour. Similarly, in males, stress decreased pp38 but promoted nuclear translocation of pJNKs and pERKs. These stress alterations of pMAPKs in males were not associated with BDNF expression and depressive-like behaviour. Fluoxetine treatment in stressed females upregulated whole pMAPK signalling particularly those in nucleus which was followed with BDNF expression and normalization of behaviour. In stressed males, fluoxetine affected only cytosolic pJNKs, while nuclear pMAPK signalling and BDNF expression were unaffected even though fluoxetine normalized behaviour. Overall, our results suggest existence of gender-specific mechanism of fluoxetine on nuclear pMAPK/BDNF signalling and depressive-like behaviour and reinforce the antidepressant dogma that females and males respond differently to certain antidepressants.